Trial Profile
A prospective study investigating the effect of micafungin in patients with urinary tract infections due to candida spp resistant to fluconazole
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 28 Oct 2015 New trial record
- 18 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy